Dialybrid attended LSI (Life Science Intelligence) Europe ’25 Emerging MedTech Summit, held in London (UK) on September 8th-11th, 2025, presenting the company and the preclinical development of Silkothane® Arteriovenous Graft, meeting investors and other emerging players, and exchanging views on MedTech innovation.
Dialybrid @ LSI Europe ‘25, London




